|
HHS H5N1 Gain-of-Function Review Group (HHG Review Group)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, OS
|
OD/OSP, NIAID
|
The Framework for Guiding HHS Funding Decisions about Research Proposals with the Potential for Generating Highly Pathogenic Avian Influenza (HPAI) H5N1 Viruses that are Transmissible among Mammals by Respiratory Droplets requires that certain research proposals undergo additional review at both the funding agency and Departmental (HHS) levels prior to funding. The HHS Department-level review is performed by the HHG Review Group, which brings to bear multidisciplinary interagency expertise in science, countermeasure development and availability, national security, law, public health preparedness and response, biodefense, select agent regulations, and science and public health policy. The purpose of the HHS Department-level review includes review of the funding agency''s risk assessment, consideration of whether additional factors may alter assessment of whether the research can be funded, determination of which measures are needed to mitigate risks, consideration of the overall HHS influenza research portfolio, and determination of whether the proposal is acceptable for HHS funding.
|
|
HHS Influenza Diagnostics Working Group
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA
|
NIAID
|
This Working Group shares information on influenza diagnostics initiatives and programs funded across different Federal agencies.
|
|
HHS Initiative on Multiple Chronic Conditions
|
Committee, Work group, Advisory group, or Task Force
|
CDC, CMS, FDA, OS
|
OD/OSP, NIA, OD/DPCPSI/OBSSR
|
Recognizing the importance of Multiple Chronic Conditions (MCC) to patients, caregivers, and the health care system, the Assistant Secretary for Health convened an HHS-wide work group on MCC to identify options for improving the health of this population. The work group, in conjunction with other stakeholders, developed Multiple Chronic Conditions: A Strategic Framework. The Framework serves as a national-level roadmap for assisting HHS programs and public and private stakeholders to improve the health of individuals with MCC.
|
|
HHS Intersection of HIV/AIDS, Violence Against Women and Girls (VAWG), & Gender-Related Health Disparities Working Group
|
Committee, Work group, Advisory group, or Task Force
|
ACF, CDC, HRSA, OS, SAMHSA
|
NIMH, NIAAA, NICHD, NIDA
|
This inter-agency workgroup focuses on working with the White House on a report on the Intersection of HIV/AIDS, Violence Against Women and Girls (VAWG), and Gender-Related Health Disparities, providing updates to the report and advancing research in this area.
|
|
HHS Lyme and Tick Borne Diseases Work Group
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, OS
|
NIAID
|
This work group involves members from agencies including the Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), and National Institutes of Health (NIH) with the purpose of continued coordination and communication of activities, policy updates, events, agency highlights and other shared interests relating to Lyme Disease and other tick-borne diseases.
|
|
HHS National HIV/AIDS Strategy Implementation Group
|
Committee, Work group, Advisory group, or Task Force
|
ACF, AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG
|
OD/DPCPSI/OAR
|
Trans DHHS Committee charged with addressing issues of and/or related to AIDS.
|
|
HHS National Promotores de Salud Initiative
|
Public Education Campaign
|
AHRQ, CDC, CMS, HRSA, SAMHSA
|
NHLBI
|
Community health workers (CHWs) and promotores de salud are frontline public health workers who serve as a link between health/social services and communities to facilitate access to services and improve the quality and cultural competence of service delivery. The purpose of the collaborative activity was to establish the National Promotores de Salud Initiative in partnership with HHS agencies to: establish a steering committee, develop a national recognition for promotores, and develop a HHS Portal for promotores and a national database system to connect with the promotores networks.
|
|
HHS Nutrition Policy Board
|
Committee, Work group, Advisory group, or Task Force
|
ACF, CDC, FDA, HRSA, IHS, OS, SAMHSA
|
NIDDK
|
This Board coordinates the Department''s nutrition policy development and program implementation and is the principle point of contact with USDA for nutrition policy.
|
|
HHS Tissue and Organ Donor Epidemiology Study (TODES) Working Group
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, HRSA
|
NHLBI
|
The Working Group supports the design and conduct of TODES.
|
|
HHS Violence Against Women Steering Committee
|
Committee, Work group, Advisory group, or Task Force
|
ACF, AHRQ, CDC, HRSA, IHS, OS, SAMHSA
|
OD/DPCPSI/ORWH, NIA, NIAAA, NICHD, NIDA, NIMH, NLM, OD/DPCPSI
|
The HHS Violence Against Women Act (VAWA) steering committee is chaired by the Office on Women''s Health (OWH). The VAWA committee has the responsibility for coordinating the Department of Health and Human Services (HHS) response to issues related to violence against women and their children, and also coordinates HHS violence related activities with those of other Federal agencies. This committee collaborates with the Department of Justice to implement the VAW Act.
|